Results 11 to 20 of about 5,138,951 (296)
Aspect of Thrombolytic Therapy: A Review
The Scientific World Journal, 2014 Thrombolytic therapy, also known as clot busting drug, is a breakthrough treatment which has saved untold lives. It has been used in the clinical area to treat venous and arterial thromboembolic complaints which are a foremost cause of death.
Md. Ramjan Ali +6 more
doaj +2 more sources
Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke [PDF]
Journal of Stroke, 2013 Background and PurposeWidespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis. There are few reports, however, regarding repeated thrombolysis
Han Soo Yoo +9 more
doaj +2 more sources
Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China. [PDF]
PLoS ONE, 2014 Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy.
Juan Yang +7 more
doaj +1 more source
Nanomedicine progress in thrombolytic therapy.
Biomaterials, 2020 Thrombotic occlusions of blood vessels are responsible for life-threatening cardiovascular disorders such as myocardial infarction, ischemic stroke, and venous thromboembolism.
Alina Zenych +2 more
semanticscholar +1 more source
Sakarya Tıp Dergisi, 2021 Objective: Neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios play an important role in monitoring the progression of the disease and determining the course of the disease in patients with acute pulmonary thromboembolism (APTE).
Ayhan Coşgun, Hüseyin Ören
doaj +1 more source
Евразийский Кардиологический Журнал, 2023 Presented clinical case report illustrates nonstandart approach use repeat thrombolytic therapy patient 49 y.o. with acute circular – apical myocardial infarction, after noneffective primary systemic thrombolytic therapy rtPA.
D. V. Bosikov +3 more
doaj +1 more source
Tratamento trombolítico do enfarte agudo do miocárdio. Primeira de três partes.
Acta Médica Portuguesa, 1998 I-Rationale of thrombolytic therapy in acute myocardial infarction (AMI). II-Thrombolytic drugs. III-Effects of thrombolytic therapy on mortality. IV-Studies comparing the effects of various thrombolytic agents on mortality.
J T Soares-Costa +2 more
doaj +1 more source
Research in Cardiovascular Medicine, 2016 Background: Thrombolytic therapy in patients with sub-massive pulmonaryembolism (SMPTE) needs further assessment. Objectives: The current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with SMPTE ...
Hasan Allah Sadeghi +4 more
doaj +1 more source
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis [PDF]
, 2007 Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis after an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered.
Abrams, Keith R. +6 more
core +4 more sources
Mismatch-based delayed thrombolysis: a meta-analysis [PDF]
, 2010 <p><b>Background and Purpose</b>: Clinical benefit from thrombolysis is reduced as stroke onset to treatment time increases. The use of "mismatch" imaging to identify patients for delayed treatment has face validity and has been used in
Anthony J. Furlan +6 more
core +1 more source